Huadong Medicine Co., Ltd
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
28.95 | 69.4 | -58.28% | 23.19 | +24.86% |
| P/S |
|
1.9 | 6.51 | -70.8% |
|
|
| P/BV |
|
3.83 | 3.96 | -3.19% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
22.59 | 11.85 | 90.66% |
|
|
| Ev/S |
|
1.88 | 5.98 | -68.55% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0345 | 0.0396 | -12.87% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
10.05 | 20.39 | -50.7% | 10.67 | -5.8% |
| ROE |
|
13.72 | 11.95 | 14.85% |
|
|
| ROA |
|
6.74 | 5.4 | 24.78% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
6.56 | 16.23 | -59.59% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.3811 | 14.63 | -97.39% | 0.4292 | -11.21% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
0.5843 | 3.6 | -83.77% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
1.73/10
|
0.69 | 1.83 | -62.36% | 0.8243 | -16.29% |
| Number of years of dividend growth |
|
0 | 1.44 | -100% | ||
| DSI |
|
0.8571 | 0.9113 | -5.94% |
|
|
| Average dividend growth |
|
-9.15 | 10.4 | -187.98% |
|
|
| Average percentage for 5 years |
|
0.8243 | 1.14 | -27.83% |
|
|
| Average percentage for payments |
|
71.28 | 44.8 | 59.11% |
|
|
| Difference from average difference in sector |
|
-1.14 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
14.61 | 61.43 | -76.22% | ||
| Growth impulse Ebitda in 5 years |
|
16.79 | 158.62 | -89.41% | ||
| Growth impulse Net Income in 5 years |
|
0.9151 | 66.93 | -98.63% | ||
| Growth impulse FCF in 5 years |
|
258.29 | 248.41 | 3.98% | ||
| Growth impulse EPS in 5 years |
|
52.5 | 73.29 | -28.37% |
IP Score
5.51/10
